boundlessbio.comHealthcareFounded: 2018Funding to Date: $152.05MM
Boundless Bio enables the companies researchers to interrogate ecDNA biology and maintain a robust pipeline of novel oncology targets essential to the function of cancer cells that are enabled by ecDNA.
For more details on financing and valuation for Boundless Bio, register or login.
View Enterprise Value for Boundless Bio.
To read this article and more news on Boundless Bio, register or login.